Sebastian AMIGORENA
11Patents
4h-index
30Co-inventors
60Inventor score
Filing activity: Mar 15, 1999 → Sep 24, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6899863B1 | Method for preparing membrane vesicles | Human Necessities | 63 | Expired |
| US6685911B1 | Sensitization process for antigen-presenting cells and means for implementing the process | Human Necessities | 27 | Expired |
| US7625573B2 | Sensitization process for antigen-presenting cells and means for implementing the process | Human Necessities | 9 | Expired |
| US10752668B2 | Lentiviral vectors for regulated expression of a chimeric antigen receptor molecule | Chemistry; Metallurgy | 4 | Active |
| US10576103B2 | Immune cells defective for SUV39H1 | Chemistry; Metallurgy | 2 | Active |
| US9827216B2 | Nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumor | Human Necessities | 1 | Active |
| US10968281B2 | Anti-LSP1 antibody | Physics | 0 | Active |
| US11622978B2 | Immune cells defective for SUV39H1 | Chemistry; Metallurgy | 0 | Active |
| US11285176B2 | Immune cells defective for Suv39h1 | Chemistry; Metallurgy | 0 | Active |
| US12371471B2 | Immune cells defective for SUV39H1 | Chemistry; Metallurgy | 0 | Active |
| US12152077B1 | Immunotherapy targeting tumor neoantigenic peptides | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.